Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.94 USD | -2.47% | -12.68% | -31.57% |
09-10 | Arrowhead Pharmaceuticals' Plozasiran Receives FDA Breakthrough Therapy Designation | MT |
09-10 | Arrowhead Pharmaceuticals Gets FDA Breakthrough Designation for Plozasiran | DJ |
MarketScreener is also available in this country: United States.
Switch edition